Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

Google has expanded NotebookLM's chat customization limit from a cramped 500 characters to a massive 10,000 characters.

Tenaya Therapeutics remains pre-revenues, and it’s a thinly traded microcap. Its tight cash runway is also a concern. Read ...

Global STD Diagnostics Market OverviewThe global STD diagnostics market is on a steady upward trajectory, projected to grow at a CAGR of 7–8% during the forecast period. This expansion is supported by ...

Ultrasensitive Molecular Amplification Market is projected to reach US$ 31.2 Bn by 2035, driven by rising chronic disease ...

The "Plant Breeding and CRISPR Plants - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Plant Breeding and CRISPR Plants was valued at US$21 ...

Key opportunities in the market include leveraging CRISPR's precision for improved crop traits, meeting food security demands amid climate change, and sustainable agriculture trendsDublin, Dec. 09, ...

The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable cures for Sickle Cell Disease.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common illnesses. So far, only 15 people have received the treatment. But, if all ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...